Neovasc Inc (US) (NASDAQ:NVCN) (TSE:NVC)’s share price traded down 5% during trading on Friday . The stock traded as low as $0.20 and last traded at $0.19. 30,036,271 shares traded hands during trading, an increase of 337% from the average session volume of 6,873,265 shares. The stock had previously closed at $0.20.
Several equities analysts recently commented on the stock. ValuEngine lowered shares of Neovasc Inc (US) from a “sell” rating to a “strong sell” rating in a research report on Sunday, December 31st. Zacks Investment Research lowered shares of Neovasc Inc (US) from a “hold” rating to a “sell” rating in a research report on Wednesday, January 31st. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $1.05 price target on shares of Neovasc Inc (US) in a research report on Friday, January 19th. Two equities research analysts have rated the stock with a sell rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $2.95.
The stock has a market cap of $20.41, a PE ratio of 0.71 and a beta of 1.86.
Neovasc Inc (US) Company Profile
Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.
Receive News & Ratings for Neovasc Inc (US) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc Inc (US) and related companies with MarketBeat.com's FREE daily email newsletter.